VH 032 amide-alkylC9-acid

Background Introduction

VH 032 amide-alkylC9-acid is a specialized E3 ligase ligand-linker conjugate, meticulously designed to facilitate the construction of PROTACs (Proteolysis Targeting Chimeras). This molecule incorporates the VH 032 moiety, which specifically binds to the von Hippel-Lindau (VHL) E3 ubiquitin ligase, combined with an amide-alkylC9-acid linker, offering optimal flexibility and spacing for efficient target protein degradation. As the demand for targeted protein degradation technology rises in medicinal chemistry and drug discovery, VH 032 amide-alkylC9-acid proves to be an essential building block.

Mechanism

VH 032 amide-alkylC9-acid operates as a bifunctional molecule, where the VH 032 portion binds selectively to the VHL E3 ligase. The amide-alkylC9-acid linker provides customizable length and chemical versatility, enabling convenient conjugation to a variety of target protein ligands. When incorporated into a PROTAC, this conjugate serves to recruit the E3 ligase to the protein of interest, triggering its ubiquitination and subsequent proteasomal degradation. This precise mechanism facilitates the targeted removal of disease-associated proteins within cells.

Applications

VH 032 amide-alkylC9-acid is widely used in the synthesis of VHL-based PROTACs for research and pharmaceutical development. Its customizable linker supports optimization of PROTAC designs targeting diverse proteins implicated in cancer, neurodegeneration, and other diseases. This conjugate enables researchers to develop next-generation therapeutics by harnessing the cell's natural proteolysis machinery, opening new avenues in drug discovery, chemical biology, and functional proteomics.

• Long alkyl C9 linker provides optimal spatial orientation for effective VHL recruitment in PROTAC design.
• Amide-terminated structure offers robust functionalization options, enabling versatile conjugation for targeted protein degradation.

The VH 032 amide-alkylC9-acid serves as a versatile E3 Ligase Ligand-Linker Conjugate in the development of PROTACs, enhancing targeted protein degradation. It offers a balanced combination of stability and reactivity, optimizing the degradation process. The following provides a detailed description of this molecule's linker, ligand, and selection of target protein ligands.

Linker: The linker in this molecule is an alkyl chain with a length of nine carbon atoms, offering moderate flexibility. This flexibility facilitates optimal spatial orientation between the ligand and target protein, while its non-cleavable nature ensures stability during the degradation process.

Ligand: The ligand component is based on VH 032, a well-characterized small molecule that binds selectively to the von Hippel-Lindau (VHL) E3 ligase. Its structural features include a robust amide linkage, contributing to high-affinity binding and efficient recruitment of the E3 ligase complex.

Reactive Site: The reactive site of this molecule is the terminal carboxylic acid group, which readily couples with the target protein ligand through amide bond formation. Recommended reaction types include carbodiimide-mediated coupling, which ensures efficient conjugation under mild conditions.

Recommended Target Protein Ligand: This molecule is compatible with a variety of electrophilic warheads, such as acrylamides, which are advantageous due to their ability to form covalent bonds with cysteine residues on target proteins. This feature facilitates the irreversible binding necessary for effective protein degradation, making it suitable for applications in cancer research and other areas of targeted therapy development.